急性缺血性卒中机械取栓后临床改善时机与长期预后的关系
研究纳入423例前循环卒中接受机械取栓的患者,334例(79.0%)在90天随访时获得良好预后(改良Rankin量表评分0-2分)。研究分析了取栓后不同时间点美国国立卫生研究院卒中量表(NIHSS)评分绝对和百分比变化对良好预后的预测价值,并定义了实质性临床改善(SCI)的最佳截断值。结果显示,临床改善延迟越短,长期良好预后的几率越高,取栓结束时NIHSS评分改善>30%是可靠的预后标志物。
要点
- 取栓结束时NIHSS改善>30%是良好预后的可靠预测指标。
- 临床改善越早,长期良好预后几率越高。
- 成功再灌注和更短治疗时间独立预测取栓结束时的临床改善。
核心结论
- 临床改善延迟越短与长期良好预后几率越高强烈相关。
- 取栓结束时NIHSS评分改善>30%是临床和研究中的可靠预后标志物。
研究设计与样本
- 研究为队列研究,纳入423例接受机械取栓的前循环卒中患者。
- 在取栓前、取栓结束时(d0)、第1天(d1)和第7天或出院时(d7)评估NIHSS评分。
主要发现
- 334例患者(79.0%)在90天随访时获得良好预后(改良Rankin量表评分0-2分)。
- 与无SCI患者(n=158)相比,SCI-d0组(n=172)良好预后的调整比值比为47.4(95%CI 22.1-101.7)。
- SCI-d1组(n=76)良好预后的调整比值比为27.7(95%CI 11.8-65.0)。
- SCI-d7组(n=17)良好预后的调整比值比为12.6(95%CI 3.8-41.4)。
- 预测SCI-d0的独立因素包括成功再灌注(比值比25.79,95%CI 12.92-51.47)和更短的治疗时间(每延迟1小时比值比0.90,95%CI 0.85-0.96)。
关键数值与推荐
- 定义实质性临床改善(SCI)的最具信息量截断值:d0为30%,d1为40%,d7为70%。
临床怎么用
- 取栓结束时NIHSS评分改善>30%可作为临床预后判断的可靠指标。
- 应关注成功再灌注和缩短治疗时间以促进早期临床改善。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- The clinical course in patients with ischemic stroke treated with mechanical thrombectomy (MT) is heterogeneous. We aimed to study the relevance of the timing of clinical improvement in the prediction of long-term outcome in patients treated with MT. Methods- We studied a cohort of 423 patients with anterior circulation stroke treated with MT, of whom 334 patients (79.0%) achieved good outcome (modified Rankin Scale score of 0-2 at 90-day follow-up). National Institutes of Health Stroke Scale scores were assessed before MT, at the end of MT (d0), at day 1 (d1), and at day 7 or discharge (d7). We explored the predictive value for good outcome of different cutoffs based on absolute and percentage changes in the National Institutes of Health Stroke Scale at each assessment (d0, d1, and d7) and selected the corresponding most informative cutoffs to define substantial clinical improvement (SCI) over time. Then, we classified patients in SCI subgroups according to the delay from MT to SCI (SCI-d0, SCI-d1, and SCI-d7) and analyzed their adjusted odds ratio for good outcome compared with patients not presenting SCI (no-SCI). Additionally, we identified the independent factors predicting SCI-d0 in multivariate models. Results- The most informative cutoffs were 30% at d0, 40% at d1, and 70% at d7. The adjusted odds ratios (95% CI) for good outcome were 47.4 (22.1-101.7, n=172) for SCI-d0, 27.7 (11.8-65.0, n=76) for SCI-d1, and 12.6 for SCI-d7 (95% CI, 3.8-41.4, n=17) compared with no-SCI (n=158). The independent factors predicting SCI-d0 were successful reperfusion (odds ratio, 25.79; 95% CI, 12.92-51.47) and shorter time to treatment (odds ratio per hour 0.90; 95% CI, 0.85-0.96). Conclusions- Shorter delay to clinical improvement is strongly related to better chances of a long-term good outcome, and an improvement >30% in National Institutes of Health Stroke Scale score at the end of MT represents a reliable prognostic marker for clinicians and also for clinical research.
引用
- Rudilosso S, Urra X, Amaro S, et al. Timing and Relevance of Clinical Improvement After Mechanical Thrombectomy in Patients With Acute Ischemic Stroke. Stroke. 2019. PMID: 31113338. doi:10.1161/STROKEAHA.118.024067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。